Magneto-immunoassay of cancer biomarkers: Recent progress and challenges in biomedical analysis

0543931 - ÚJF 2022 RIV NL eng J - Článek v odborném periodiku
Kavetskyy, T. - Alipour, M. - Smutok, O. - Mushynska, O. - Kiv, A. - Fink, Dietmar - Farshchi, F. - Ahmadian, E. - Hasanzadeh, M.
Magneto-immunoassay of cancer biomarkers: Recent progress and challenges in biomedical analysis.
Microchemical Journal. Roč. 167, AUG (2021), č. článku 106320. ISSN 0026-265X. E-ISSN 1095-9149
Institucionální podpora: RVO:61389005
Klíčová slova: cancer * nanobiomedicine * biomedical analysis * biotechnology * magnetic nanomaterials
Obor OECD: Analytical chemistry
Impakt faktor: 5.304, rok: 2021
Způsob publikování: Omezený přístup
https://doi.org/10.1016/j.microc.2021.106320

Ultrasensitive biomarker sensing has been used to develop novel strategies in detecting early stage cancer. Due to their unique characteristics, ie, ease of synthesis, conductivity and bio-compatibility, iron magnetic nanoparticles (MNPs) are exceptional nanomaterial in theragnostics. The current review focuses the critical role of iron MNPs in the development of several immunoassay technologies including electrochemical, electrochemiluminescent, photoelectrochemical, optical and microfluidic biosensors. Type and composition of magnetic particles, detection methods, relative specificity and sensitivity is discussed. Advantages and limitations of various strategies for label-free immunosensing of cancer biomarkers are explored.
Trvalý link: http://hdl.handle.net/11104/0321025